POLL: Which 2022 Psoriasis FDA Approval Were You Most Excited About?

Poll

Click here to answer this week's poll.

Which 2022 Psoriasis FDA Approval Were You Most Excited About?

Deucravacitinib
Tapinarof cream
Roflumilast cream
Spesolimab (generalized pustular psoriasis)
Related Videos
Related Content

POLL: Are You Attending Maui Derm NP+PA Fall 2023?

September 26th 2023

The Cutaneous Connection: An Inside Look of the Inclusive Atlas

November 4th 2021

POLL: What Strategies Have You Found Most Effective in Managing Alopecia?

September 25th 2023

The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics

September 23rd 2021

Accurately Recognizing and Diagnosing Psoriasis in Patients With Skin of Color

September 20th 2023

Dermoscopy Aids in Diagnosing Psoriasis Vulgaris and Nail Psoriasis

September 19th 2023

POLL: Are You Attending Maui Derm NP+PA Fall 2023?

September 26th 2023

The Cutaneous Connection: An Inside Look of the Inclusive Atlas

November 4th 2021

POLL: What Strategies Have You Found Most Effective in Managing Alopecia?

September 25th 2023

The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics

September 23rd 2021

Accurately Recognizing and Diagnosing Psoriasis in Patients With Skin of Color

September 20th 2023

Dermoscopy Aids in Diagnosing Psoriasis Vulgaris and Nail Psoriasis

September 19th 2023

POLL: Are You Attending Maui Derm NP+PA Fall 2023?

September 26th 2023

The Cutaneous Connection: An Inside Look of the Inclusive Atlas

November 4th 2021

POLL: What Strategies Have You Found Most Effective in Managing Alopecia?

September 25th 2023

The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics

September 23rd 2021

Accurately Recognizing and Diagnosing Psoriasis in Patients With Skin of Color

September 20th 2023

Dermoscopy Aids in Diagnosing Psoriasis Vulgaris and Nail Psoriasis

September 19th 2023
© 2023 MJH Life Sciences

All rights reserved.